M&G »

Blueprint Medicines shares owned by M&G

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by M&G from 13F filings

Historical chart of M&G investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by M&G consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by M&G

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.1M 98k 93.00

More positions owned by M&G

Ferguson Enterprises Common Stock New (FERG)
Interdigital Note 3.500% 6/0 (Principal)
Diversified Energy Company P Shs New (DEC)
Burford Cap Ord Shs (BUR)
Microsoft Corporation (MSFT)
Amcor Ord (AMCR)
Broadcom (AVGO)
Methanex Corp (MEOH)
Bristol Myers Squibb (BMY)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Nextera Energy (NEE)
V.F. Corporation (VFC)
UnitedHealth (UNH)
CRH Ord (CRH)

View all positions for M&G

Top funds holding Blueprint Medicines

BlackRock
BlackRock
Vanguard Group
T. Rowe Price Associates
Rock Springs Capital Management
State Street Corporation
Jane Street
William Blair Investment Management
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Lord, Abbett & Co
Pictet Asset Management Holding SA
Alliancebernstein
Invesco

View all funds holding Blueprint Medicines